Phenotypic pliancy and the breakdown of epigenetic polycomb mechanisms
PLOS Computational Biology · 2023
DOI: 10.1371/journal.pcbi.1010889 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Computational Biology, 2023. Verfasst von Maryl Lambros und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Systems and Computational Biology, Albert Einstein College of Medicine, Bronx, New York, United States of America. Hauptthemen laut MEDLINE: Drosophila Proteins, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIDA NIH HHS, NIH.
Abstract (Originalsprache)
Epigenetic regulatory mechanisms allow multicellular organisms to develop distinct specialized cell identities despite having the same total genome. Cell-fate choices are based on gene expression programs and environmental cues that cells experience during embryonic development, and are usually maintained throughout the life of the organism despite new environmental cues. The evolutionarily conserved Polycomb group (PcG) proteins form Polycomb Repressive Complexes that help orchestrate these developmental choices. Post-development, these complexes actively maintain the resulting cell fate, even in the face of environmental perturbations. Given the crucial role of these polycomb mechanisms in providing phenotypic fidelity (i.e. maintenance of cell fate), we hypothesize that their dysregulation after development will lead to decreased phenotypic fidelity allowing dysregulated cells to sustainably switch their phenotype in response to environmental changes. We call this abnormal phenotypic switching phenotypic pliancy . We introduce a general computational evolutionary model that allows us to test our systems-level phenotypic pliancy hypothesis in-silico and in a context-independent manner. We find that 1) phenotypic fidelity is an emergent systems-level property of PcG-like mechanism evolution, and 2) phenotypic pliancy is an emergent systems-level property resulting from this mechanism’s dysregulation. Since there is evidence that metastatic cells behave in a phenotypically pliant manner, we hypothesize that progression to metastasis is driven by the emergence of phenotypic pliancy in cancer cells as a result of PcG mechanism dysregulation. We corroborate our hypothesis using single-cell RNA-sequencing data from metastatic cancers. We find that metastatic cancer cells are phenotypically pliant in the same manner as predicted by our model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Systems and Computational Biology, Albert Einstein College of Medicine, Bronx, New York, United States of America.
- Dominick P. Purpura Department of Neuroscience, Albert Einstein College of Medicine, Bronx, New York, United States of America.
- Department of Pathology, Albert Einstein College of Medicine, Bronx, New York, United States of America.
- Santa Fe Institute, Santa Fe, New Mexico, United States of America.
ORCID-Profile: Maryl Lambros, Aviv Bergman
Förderung
- NCI NIH HHS
- NIDA NIH HHS
- NIH
Zitieren
APA
Lambros, M., Sella, Y., & Bergman, A. (2023). Phenotypic pliancy and the breakdown of epigenetic polycomb mechanisms. PLOS Computational Biology. https://doi.org/10.1371/journal.pcbi.1010889
Vancouver
Lambros M, Sella Y, Bergman A. Phenotypic pliancy and the breakdown of epigenetic polycomb mechanisms. PLOS Computational Biology. 2023. doi:10.1371/journal.pcbi.1010889
BibTeX
@article{Lambros2023,
author = {Lambros, Maryl and Sella, Yehonatan and Bergman, Aviv},
title = {Phenotypic pliancy and the breakdown of epigenetic polycomb mechanisms},
journal = {PLOS Computational Biology},
year = {2023},
doi = {10.1371/journal.pcbi.1010889}
}
EUVIMED